International journal of clinical pediatric dentistry · 2025
Evaluation of Chitosan (Axiostat®) as a Pulpotomy Agent in Primary Molars: An In Vivo Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Krishna Nidhish, Rai Kavita, Manju R, Lolayekar Nikita
Аннотация
BACKGROUND: In primary teeth, pulpotomy is a well-established intervention for managing cariously exposed coronal pulp, with formocresol long considered the gold-standard medicament. Recent research focuses on wound-healing phenomena and the use of regenerative materials like chitosan owing to its functional versatility and unique characteristics.
AIM: To assess the clinical and radiographic outcomes of using chitosan as a pulpotomy agent in primary molars.
MATERIALS AND METHODS: Children aged 4-9 years, free from systemic illnesses and in need of pulpotomy, were selected. About 50 teeth were assigned to two groups: group I (chitosan) and group II (formocresol), and all treated teeth received stainless-steel crowns. Clinical and radiographic parameters were assessed at 1, 3, and 6 months posttreatment. The Chi-squared test was applied to compare the parameters and analyze the differences between the groups at the various time intervals.
RESULTS: Group I (chitosan) demonstrated a clinical and radiographic success rate of 95.6%, while group II (formocresol) achieved 100%. The variation between the groups was not statistically significant.
CONCLUSION: The study indicated that chitosan (Axiostat®) can be considered a reliable pulpotomy agent in primary dentition and an effective substitute for formocresol.
HOW TO CITE THIS ARTICLE: Krishna N, Rai K, Manju R, et al. Evaluation of Chitosan (Axiostat®) as a Pulpotomy Agent in Primary Molars: An In Vivo Study. Int J Clin Pediatr Dent 2025;18(S-1):S61-S65.
AIM: To assess the clinical and radiographic outcomes of using chitosan as a pulpotomy agent in primary molars.
MATERIALS AND METHODS: Children aged 4-9 years, free from systemic illnesses and in need of pulpotomy, were selected. About 50 teeth were assigned to two groups: group I (chitosan) and group II (formocresol), and all treated teeth received stainless-steel crowns. Clinical and radiographic parameters were assessed at 1, 3, and 6 months posttreatment. The Chi-squared test was applied to compare the parameters and analyze the differences between the groups at the various time intervals.
RESULTS: Group I (chitosan) demonstrated a clinical and radiographic success rate of 95.6%, while group II (formocresol) achieved 100%. The variation between the groups was not statistically significant.
CONCLUSION: The study indicated that chitosan (Axiostat®) can be considered a reliable pulpotomy agent in primary dentition and an effective substitute for formocresol.
HOW TO CITE THIS ARTICLE: Krishna N, Rai K, Manju R, et al. Evaluation of Chitosan (Axiostat®) as a Pulpotomy Agent in Primary Molars: An In Vivo Study. Int J Clin Pediatr Dent 2025;18(S-1):S61-S65.